Market Place
Sourcing Support
All News #Library
Biotech
Personalis to showcase ultrasensitive ctDNA data at AACR 2026
13 Apr 2026 //
BUSINESSWIRE
Personalis NeXT Personal Wins Medicare Coverage for Lung Cancer
10 Feb 2026 //
BUSINESSWIRE
Personalis Expands Evidence For Ultrasensitive ctDNA Monitoring
02 Feb 2026 //
BUSINESSWIRE
Personalis Publishes Study On Ultrasensitive Ctdna Testing
17 Dec 2025 //
BUSINESSWIRE
New Study: NeXT Detection`s Key Role in Lung Cancer
11 Dec 2025 //
BUSINESSWIRE
Personalis Reveals Latest Results From Landmark Lung Cancer Trial
16 Oct 2025 //
BUSINESSWIRE
CATE Trial: ctDNA-Guided Breast Cancer Treatment with NeXT Test
10 Sep 2025 //
BUSINESSWIRE
Personalis` NeXT Personal Predict Cervical Cancer Recurrence Risk
03 Jun 2025 //
BUSINESSWIRE
Personalis to Attend Craig-Hallum Investor Conference
14 May 2025 //
BUSINESSWIRE
Personalis Reports Q4 and Full Year 2024 Financial Results
27 Feb 2025 //
BUSINESSWIRE
Personalis Reports Q3 2024 Financial Results
06 Nov 2024 //
BUSINESSWIRE
Personalis to Present at the Stifel 2024 Healthcare Conference
05 Nov 2024 //
BUSINESSWIRE
Personalis NeXT Personal MRD Test Data Presented At ESMO
16 Sep 2024 //
BUSINESSWIRE
Personalis to Present at the 21st Annual Morgan Stanley Global Conference
29 Aug 2023 //
BUSINESSWIRE
Personalis, National Cancer Center Hospital East, and Ono Collaborate
16 May 2023 //
BUSINESSWIRE
Personalis to Announce First Quarter 2023 Financial Results
19 Apr 2023 //
BUSINESSWIRE
Personalis to Participate at 22nd Annual Needham Virtual Healthcare Conference
05 Apr 2023 //
BUSINESSWIRE
Personalis Joins UK Cancer Research Organizations to Evaluate Cancer Recurrence Detection
05 Apr 2023 //
BUSINESSWIRE
Personalis, AstraZeneca to Explore ctDNA Testing in R&D
07 Mar 2023 //
CONTRACT PHARMA
Personalis and Moderna Sign New Agreement to Leverage NeXT Platform
03 Feb 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.